The new technology operates on a dialysis principle, aiming to prevent the spread of metastases, which account for the majority of cancer-related deaths. According to South China Morning Post via Kazinform, the device uses a microfilter equipped with specialized antibodies to trap cancer cells while leaving healthy ones intact.
Experimental results and survival rates
The effectiveness of the prototype was tested on mice with breast cancer. Researchers found that combining blood purification with surgery and chemotherapy significantly improved survival outcomes compared to traditional methods.
Experimental outcomes
Despite these results, the development is currently in the proof-of-concept stage. Before human trials can begin, the team must adapt the device to process larger blood volumes, ensure the safety of repeated procedures, and conduct studies on larger animals. Future applications may include treating lung, stomach, and intestinal cancers.
Context
The research was conducted by scientists at Shanghai Jiao Tong University. This development follows recent reports that China has approved its first drug targeting a rare type of cancer.
